MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Afolia | |
New | Amcal Famciclovir Once | |
New | Angusta | |
New | Blooms The Chemist Famciclovir Once | |
New | Blooms The Chemist Mirtazapine | |
New | Blooms the Chemist Paroxetine | |
New | Blooms the Chemist Prochlorperazine | |
New | BTC Candesartan | |
New | BTC Ezetimibe | |
New | BTC Tamsulosin SR | |
New | Calquence Tablets | |
New | Captopril Sugar Free Oral Solution (Syrimed) | |
New | Celestone Soluspan Injectable Suspension, USP (USA) | |
New | Co-Trimoxazole Paediatric Suspension (Aspen) (Reach) | |
New | Dymista Allergy | |
New | Ethambutol Lupin | |
New | Fingolimod-Teva | |
New | Fluticasone Salmeterol Ciphaler 500/50 | |
New | Gliclazide Lupin MR | |
New | Hydromorphone Hydrochloride Extended-Release Tablets (Camber) | |
New | Kerendia | |
New | Leqvio | |
New | Olsetan | |
New | Pharmacy Action Cold & Flu PSE | |
New | Pharmacy Care Famciclovir Once | |
New | Tranexamic Acid Lupin | |
New | Vaxelis | |
New | Wockhardt Heparin Sodium Flushing Solution (UK) | |
New | Zyamis | |
Reinstated | Clindamyk | |
Revised | Abevmy | Adverse Effects (Undesirable Effects), Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Abraxane | TGA Date |
Revised | AKM Fingolimod | List of Excipients |
Revised | Allertine | TGA Date |
Revised | Allopurinol Sandoz | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Alphamox | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Amikacin SXP | Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Amoxycillin Sandoz Capsules and Suspension | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Amoxycillin Sandoz Tablets | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Anoro Ellipta | Adverse Effects (Undesirable Effects) |
Revised | APO-Candesartan HCTZ | Sponsor |
Revised | APO-Clindamycin | TGA Date |
Revised | APO-Modafinil | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Physicochemical Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Sponsor |
Revised | APO-Terbinafine | Sponsor |
Revised | APO-Varenicline (Canada) | Presentation |
Revised | APO-Ziprasidone | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Arcoxia | Adverse Effects (Undesirable Effects) |
Revised | ARX-Lercanidipine | Product Name change |
Revised | Atozet | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Augmentin Duo, Augmentin Duo Forte Tablets | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Azactam | Qualitative and Quantitative Composition |
Revised | Blooms the Chemist Candesartan HCTZ | Adverse Effects (Undesirable Effects) |
Revised | Bosentan APO | Sponsor |
Revised | Calindamin | TGA Date |
Revised | Cefuroxime SXP | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Celapram | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition |
Revised | Ceptolate | Nature and Contents of Container |
Revised | Cilamox | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Cilatil | Nature and Contents of Container |
Revised | Citalopram Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Cosamide 50 | Nature and Contents of Container |
Revised | Cosmegen | TGA Date |
Revised | Cozavan | List of Excipients, Nature and Contents of Container |
Revised | Darzalex SC | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Dasatinib Dr.Reddy's | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | DBL Carboplatin Injection | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Dexamethasone Juno | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Dilatrend | TGA Date |
Revised | Durogesic | Overdose |
Revised | Eliquis | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Erlyand | Pharmacological Properties |
Revised | Estalis Continuous | TGA Date |
Revised | Estalis Sequi | TGA Date |
Revised | Estradot | TGA Date |
Revised | Evrysdi | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Evusheld | Pharmacological Properties |
Revised | Ezalo Composite Pack | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ezecrest Composite Pack | TGA Date |
Revised | Foradile | Sponsor |
Revised | Fosamax Plus | Special Warnings and Precautions for Use |
Revised | Glypressin Solution | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Imatinib-DRLA | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Imbruvica | Nature and Contents of Container |
Revised | Imoclone | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Inqovi 35/100 | Dose and Method of Administration |
Revised | Invega Sustenna | Dose and Method of Administration |
Revised | Kanuma | Dose and Method of Administration |
Revised | Levetiracetam Medsurge | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Libtayo | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Lipex | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Lipiodol Ultra Fluid | New contraindication |
Revised | LPV | Qualitative and Quantitative Composition |
Revised | Marvelon 28 | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Maxamox | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Maxamox Powder for Oral Suspension | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Meropenem Kabi | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Mesalazine 1.2 TAKEDA | Adverse Effects (Undesirable Effects) |
Revised | Methotrexate Ebewe | Adverse Effects (Undesirable Effects) |
Revised | Mezavant | Adverse Effects (Undesirable Effects) |
Revised | MS Contin | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | MS Mono | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Mydol 15 | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Mytolac | Adverse Effects (Undesirable Effects), Overdose |
Revised | NuvaRing | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Olumiant | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Oncaspar Powder for Injection | Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Ondansetron ODT GH | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Ondansetron ODT Viatris | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Product Name change, Special Warnings and Precautions for Use |
Revised | Ondansetron ODT-DRLA | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Ondansetron SZ ODT | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Ondansetron Viatris Tablets | Product Name change, Sponsor |
Revised | Oralair | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Orkambi | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Therapeutic Indications |
Revised | Ozmep | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Parlodel | TGA Date |
Revised | Pentasa | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Pentasa Oral | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Pharmacor Fingolimod | List of Excipients |
Revised | Pharmacor Tacrolimus | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Prozac | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Rapifen | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Rosuzet Composite Pack | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Rotarix Oral Liquid | Qualitative and Quantitative Composition |
Revised | Septrin Forte | Special Warnings and Precautions for Use |
Revised | Sevredol | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Sildenafil Sandoz PHT 20 | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Simpral | Nature and Contents of Container, Sponsor, Physicochemical Properties |
Revised | Sitagliptin/Metformin Sandoz | Adverse Effects (Undesirable Effects), Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Skyrizi | Dose and Method of Administration |
Revised | Solu-Cortef | Dose and Method of Administration |
Revised | Stelara | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Tacrograf | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Targin | Pharmacological Properties |
Revised | Tecentriq | Dose and Method of Administration |
Revised | Tenofovir/Emtricitabine 300/200 ARX | List of Excipients, Nature and Contents of Container, Product Name change, Sponsor |
Revised | Tramal | Adverse Effects (Undesirable Effects) |
Revised | Ultomiris 100 mg/mL | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Vagifem Low | Adverse Effects (Undesirable Effects) |
Revised | Victoza | Adverse Effects (Undesirable Effects) |
Revised | Voltaren Rapid 25 | Sponsor |
Revised | Vytorin | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Xeomin | TGA Date |
Revised | Xifaxan 550 mg | TGA Date |
Revised | Xolair | Special Precautions for Storage |
Revised | Yasmin | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Yervoy | Dose and Method of Administration |
Revised | Zabep 20 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Zeklen | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Zinnat | Adverse Effects (Undesirable Effects) |
Revised | Ziprox | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Zocor | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Deleted | Carbidopa and Levodopa Tablets, USP (ScieGen) | |
Deleted | Cubicin | |
Deleted | Flopen | |
Deleted | Hydrocortisone Tablets (Bristol) | |
Deleted | Ircal | |
Deleted | Monace | |
Deleted | Pfizer (Australia) Carboplatin | |
Deleted | Sulfamethoxazole and Trimethoprim Tablets, USP (Aurobindo) (Medsurge) | |
Deleted | Xenetix (France) |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au